RNS Number : 3608Q
Jade Road Investments Limited
20 February 2023
 

 

‎20 February 2023‎

 

RNS

JADE ROAD INVESTMENTS LIMITED

‎("Jade Road" or the "Company")‎

Completion of Conditional Equity Fundraise

Following the Company's announcement on 31 January 2023, and as set out in more detail in the Circular to shareholders ‎dated 31 January 2023, the Company is pleased to report that it has launched its Equity Fundraise. The Company is further pleased to report that $183,427 in gross proceeds have been raised by the ‎Placing Agent on behalf of the Company ("Placing Proceeds").

The Equity Fundraise is conditionally underwritten in its entirety by the Underwriter. Following the results of the Placing and the terms of the Underwriting Agreement, the ‎Underwriter's commitment of $1,750,000 has been reduced by the Placing Proceeds to $1,566,573 at a price of £0.0075 per share. ‎The Equity Fundraise is conditional on all the resolutions being approved at the General Meeting on Monday 20 February 2023.

A further announcement will be made following the conclusion of the General Meeting on Monday 20 February 2023. Capitalised terms used in this announcement have the meanings ascribed to them in the ‎announcement of 31 January 2023.

FOR FURTHER INFORMATION, PLEASE CONTACT:

Jade Road Investment Limited

+44 (0) 778 531 5588

John Croft




Hybridan LLP - Corporate Broker

+44 (0)203 764 2341

Claire Noyce




WH Ireland Limited - Nominated Adviser

+44 (0) 20 7220 1666

James Joyce


Andrew de Andrade




Lionsgate Communications - Communications Adviser

+44 (0) 779 189 2509

Jonathan Charles



This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROINKCBQOBKDABD